Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Qiming's Portfolio Company InventisBio Lists on STAR Market 2022-07-25 11:55
Qiming's Portfolio Company InventisBio Lists on STAR Market 2022-07-25 11:55
Qiming Venture Partners Announces Closing of Funds Totaling US$3.2 Billion 2022-07-11 09:00
CanSinoBIO's COVID-19 Vaccine Convidecia™ Receives WHO Emergency Use Listing 2022-05-19 23:28
CanSinoBIO Rebrands to Reflect Commitment to Life Sciences Research 2022-04-25 08:00
Qiming's Nisa Leung, Duane Kuang Named on 2022 Forbes Midas List 2022-04-13 09:20
CanSinoBIO's COVID-19 mRNA Vaccine Receives Approval of Clinical Trial Application in China 2022-04-04 08:30
CanSinoBIO's Convidecia™ Approved as Heterologous Booster in Malaysia and Indonesia 2022-03-22 21:32
Latest Study Shows Advantages of CanSinoBIO's Convidecia™ as Heterologous Booster against Omicron Variant 2022-03-14 08:00
CanSinoBIO's Convidecia™ Approved as Heterologous Booster in China 2022-02-21 08:05
Latest Study Shows Encouraging Results of CanSinoBIO's Inhaled COVID-19 Vaccine as Heterologous Booster 2022-01-11 15:15
CanSinoBIO Announces Approval for its MCV4 Product Menhycia™ in China 2022-01-09 10:09
Convidecia™ Phase III Results Published in The Lancet 2021-12-24 15:28
CanSinoBIO Receives European GMP Certification for its COVID-19 Vaccine Convidecia™ 2021-05-24 17:00
CanSinoBIO Announces Approval for its Single-Dose COVID-19 Vaccine Convidecia™ in Chile 2021-04-08 21:17
CanSinoBIO Announces Approval for its Single-Dose COVID-19 Vaccine Convidecia™ in Hungary 2021-03-23 00:43
CanSinoBIO's Successful Listing on STAR Market Makes it the Initial Dual Listing Vaccine Company 2020-08-13 10:00
CanSino Biologics and Precision NanoSystems Announce Collaboration to Co-Develop a COVID-19 RNA Vaccine 2020-05-20 21:00
1